Ultragenyx Pharmaceutical RARE Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Ultragenyx Pharmaceutical’s reported figures.
The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ultragenyx Pharmaceutical's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ultragenyx Pharmaceutical's enterprise value?
- Ultragenyx Pharmaceutical (RARE) reported enterprise value of $1.83B in Q4 2025.
- How has Ultragenyx Pharmaceutical's enterprise value changed year-over-year?
- Ultragenyx Pharmaceutical's enterprise value decreased by 51.1% year-over-year, from $3.75B to $1.83B.
- What is the long-term trend for Ultragenyx Pharmaceutical's enterprise value?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's enterprise value has grown at a -26.9% compound annual growth rate (CAGR), from $8.77B to $1.83B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.